Invention Grant
US07855288B2 Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases 失效
吡咯并[1,2-d] [1,2-4]三嗪作为c-Jun N末端激酶(JNK)和p-38激酶的抑制剂

  • Patent Title: Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
  • Patent Title (中): 吡咯并[1,2-d] [1,2-4]三嗪作为c-Jun N末端激酶(JNK)和p-38激酶的抑制剂
  • Application No.: US11576301
    Application Date: 2005-10-25
  • Publication No.: US07855288B2
    Publication Date: 2010-12-21
  • Inventor: Qing Dong
  • Applicant: Qing Dong
  • Applicant Address: CH Basel
  • Assignee: Novartis AG
  • Current Assignee: Novartis AG
  • Current Assignee Address: CH Basel
  • Agency: Hoxie & Associates LLC
  • International Application: PCT/US2005/038071 WO 20051025
  • International Announcement: WO2006/047354 WO 20060504
  • Main IPC: C07D487/04
  • IPC: C07D487/04 A61K31/53 A61P19/02 A61P1/00
Pyrrolo [1,2-d] [1,2-4] triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
Abstract:
A compound of formula (I): wherein the substituents are as defined in the specification as inhibitor of C-Jun N terminal Kinases (JNK) and P-38 Kinases.
Information query
Patent Agency Ranking
0/0